Fresenius Group Overview

The Health Care Group
Stories
Archive „Stories“
Investors
Contact

Fresenius SE & Co. KGaA

Investor Relations & Sustainability

+49 (0) 6172 608-2485
ir-fre@fresenius.com
Media
- News
- Social Media
- Calendar
- Contacts
- Media Center
Contact

Matthias Link

Senior Vice President Corporate Communications

T: +49 (0) 6172 608-2872
matthias.link@fresenius.com
Careers
Menu
Filter results
- Chapter
- Format
  - Website (0)
  - PDF (0)
Share
- Facebook
- Twitter
- LinkedIn
- Xing
- E-Mail
Services
- Deutsch
- Print
- Contact
- RSS

A robot at the operating table

Fresenius Helios uses the latest robotic technology to make surgery gentler for patients – for example at Helios Hospital Erfurt in Germany.
Read the story
My 50 years of dialysis

I am Susanne Williams from Adelaide. I am 66 years old – and this is my story of 50 years of dialysis.
Read the story
Midwife, a dream job

After her son was born, Lea Zerbe decided to become a midwife and enrolled in a training program at Helios Mariahilf Hospital in Hamburg.
Read the story
In battle against the coronavirus

Fresenius is taking comprehensive measures to ensure healthcare is available for patients during the COVID-19 pandemic.
Read the story

News

Fresenius wins tenth consecutive Potentialpark award for Germany’s best online offering for job applicants

The market research institute Potentialpark has honored the global healthcare group Fresenius for the tenth consecutive year as the German company with the best overall Internet offering for job applicants.
February 24, 2021Fresenius
Fresenius achieves 2020 targets and expects healthy business development in 2021 despite ongoing COVID-19 impact

Stephan Sturm, CEO of Fresenius, said: ”The pandemic year 2020 showed emphatically the importance of forward-thinking, effective and efficient healthcare. Fresenius is making a vital contribution here, in many different areas of medicine. (...)
February 23, 2021Fresenius
Fresenius Medical Care achieves 2020 targets, expects significant COVID-19 impact in 2021 and confirms 2025 outlook

Rice Powell, Chief Executive Officer of Fresenius Medical Care, said: “The COVID-19 pandemic might be the most decisive challenge the world has faced in recent decades. I am incredibly proud of our employees and their tireless efforts to provide our patients with their life-sustaining treatments. (...)
February 23, 2021Fresenius Medical Care
Fresenius Kabi India reaches resolution to conclude 2013 Kalyani investigation

February 09, 2021Fresenius Kabi

Fresenius Kabi expands facilities in Austria

February 09, 2021Fresenius Kabi
Fresenius achieves FY/20 guidance, targets healthy sales growth and at least broadly stable net income in FY/21

February 01, 2021Fresenius

Fresenius Medical Care anticipates significant negative COVID-19 impact on 2021 net income; confirms mid-term targets

February 01, 2021Fresenius Medical Care
Fresenius Medical Care’s Frenova enrolls patients in initiative to build world’s largest genomic registry targeting kidney disease

January 11, 2021Fresenius Medical Care

Fresenius Medical Care expands critical care offering with ExThera Medical’s Seraph 100 adsorber

January 07, 2021Fresenius Medical Care
Fresenius Helios acquires fertility services provider Eugin Group

December 21, 2020Fresenius Helios

Brief News
Fresenius Medical Care improves in climate and water ranking

Fresenius Medical Care has improved in this year's ranking of the non-profit organization CDP (formerly "Carbon Disclosure Project"). In both the 'Climate' and 'Water' areas, Fresenius Medical Care improved to category B and B-, respectively. With the ranking in the second highest category B, Fresenius Medical Care is one of the leading companies in the health care sector. Companies in categories A and B are characterized by transparency, coordinated climate and water protection measures, and the implementation of corresponding best-practice approaches. CDP is one of the most renowned climate and environmental rankings in the capital market. More than 515 investors use the annual results to evaluate climate protection activities and climate-related risks and opportunities of the companies assessed.

December 14, 2020Fresenius Medical Care
Brief News
Fresenius improves in climate ranking

Fresenius has once again improved in this year's CDP ranking (formerly "Carbon Disclosure Project"). With a ranking in the second highest category B, Fresenius is one of the leading companies in the health care sector, both in Europe and globally. Companies in categories A and B are characterized by transparency, coordinated climate protection measures and the implementation of corresponding best-practice approaches. CDP is one of the most renowned climate and environmental rankings in the capital market. More than 515 investors use the annual results to evaluate climate protection activities and climate-related risks and opportunities of the companies assessed.

December 11, 2020Fresenius

Fresenius Medical Care employee in Schweinfurt is Germany’s best apprentice in her specialty as electronics technician

December 07, 2020Fresenius Medical Care
Brief News
Fresenius Medical Care included for 11th time in Dow Jones Sustainability Index

Fresenius Medical Care, the world’s leading provider of products and services for people with chronic kidney failure, has been recognized for the 11th time as a sustainability leader with inclusion in the Dow Jones Sustainability Index (DJSI Europe). The DJSI Europe index represents the top 20 percent of the largest 600 European companies in the S&P Global BMI, based on the international investment company S&P Global’s analysis of their economic, environmental and social performance.

November 16, 2020Fresenius Medical Care

Brief News
Fresenius Helios reporting figures on intensive care occupancy

Fresenius Helios has started publishing daily figures on the occupancy rate for intensive care beds in its 86 German hospitals. The website of each hospital will report the number of COVID-19 patients in the hospital’s regular and intensive care wards. It will also publish figures from the Robert Koch Institute, Germany’s national health agency, on the number of new infections in the surrounding region. Helios’ goal is to increase transparency and facilitate a data-based assessment of the pandemic at the local level. Helios Germany currently has a total of 1,300 intensive care beds across the country and could add an additional 1,000 on short notice, in the event of a sharp increase in COVID-19 hospitalizations.

November 02, 2020Fresenius Helios
Fresenius continues to demonstrate resilience amid the COVID-19 pandemic

October 29, 2020Fresenius

Fresenius Medical Care continues solid revenue and strong earnings growth in the third quarter

October 29, 2020Fresenius Medical Care
Brief News
Fresenius Medical Care gets FDA approval for Biofine® PD solution bags

Fresenius Medical Care North America announced today that the U.S. Food and Drug Administration (FDA) has approved DELFLEX® peritoneal dialysis solutions in Biofine®, an innovative bag material. The milestone marks another important step in the company’s commitment to grow home dialysis through new and improved products. Biofine material generates less waste and is PVC-free, to the benefit of the environment. The new Biofine peritoneal dialysis solutions bag has a user-friendly design for easy storage and use, and will be produced on a new manufacturing line in the company’s Knoxville, Tennessee plant. It is expected to be made available first to a limited number of U.S. patients this fall.

October 20, 2020Fresenius Medical Care

Fresenius announces changes to Supervisory Board

October 13, 2020Fresenius
Brief News
Fresenius Helios expands reporting on quality standards

As part of its reporting on quality standards, Fresenius Helios is publishing data on the length of patient stays, patient security and antibiotic use in the company’s German hospitals for the first time. Data from every Helios hospital is compiled in a total of 46 quality categories, including the frequency of surgical interventions and their results, and then published annually. The comparing of different hospitals’ statistics through the Quality Medicine Initiative yields specific, concrete improvements that can be implemented in day-to-day hospital operations. The initiative, which was jointly founded by Fresenius Helios, now includes more than 400 hospitals in Germany and Switzerland.

October 09, 2020Fresenius Helios